Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the "Tissue Transit Time" (TTT) in the MAG3-Tc99 Diuretic Renogram for Risk Stratification of Infants With Ureteropelvic Junction Obstruction - a Multicentric Prospective Observational Study

NCT03311256 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03311256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03311256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the "Tissue Transit Time" (TTT) in the MAG3-Tc99 Diuretic Renogram for Risk Stratification of Infants With Ureteropelvic Junction Obstruction - a Multicentric Prospective Observational Study
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
November 23, 2017
Completion date
November 24, 2021
Enrollment
119 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

renal insufficiency, acute